Aspirin, Cardiovascular and Cerebrovascular Diseases
- VernacularTitle:阿司匹林与心脑血管疾病
- Author:
Jiao WU
;
Gang ZHOU
;
Yanhui LI
- Publication Type:Journal Article
- Keywords:
aspirin;
aspirin resistance;
cardiovascular and cerebrovascular diseases;
personalized medication;
pharmacogenomics
- From:
Chinese Journal of Biochemical Pharmaceutics
2015;37(7):172-174,177
- CountryChina
- Language:Chinese
-
Abstract:
Cardiovascular and cerebrovascular diseases is the most fatal diseases in the world.The prevention and treatment of cardiovascular and cerebrovascular diseases are both basic and clinical focus.Aspirin has been used as a prevention medicine in cardiovascular and cerebrovascular diseases for over a century, which is the longest one in history.Aspirin use is estimated at 100 billion tablets annually as an analgesic, antipyretic and antiplatelet drugs.However, there are still many new findings about aspirin, such as aspirin resistance and aspirin hydrolase.This paper reviews the current research advances and future directions of aspirin in cardiovascular and cerebravascwlar diseases, mainly focuses on aspirin resistance and personalized medication.
